文献速递乳房整形与再造

预防性抗生素对二期乳房再造的影响:一项回顾性分析

The effect of prophylactic antibiotics on second-stage breast reconstruction: A retrospective analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-01-25

该单中心回顾性队列研究纳入2018年1月至2021年1月接受组织扩张器-假体置换二期乳房再造的359例患者,分析预防性抗生素选择与疗程对术后感染的影响。结果显示,除单次围手术期头孢唑林外,延长抗生素预防未显著影响术后感染可能性(p=0.581),既往乳房感染史是感染的显著预测因素(p<0.001)。

要点

  • 延长抗生素预防至7天及以上未改善3个月术后感染率预测(p=0.581)。
  • 既往乳房感染史是术后感染的显著预测因素(p<0.001)。
  • 除单次围手术期头孢唑林外,延长预防未显著影响感染可能性。

核心结论

  • 超出单次术前静脉头孢唑林剂量延长抗生素预防不降低二期乳房再造患者的并发症率。
  • 限制麻醉期后延长预防性抗生素使用可能减少副作用(如胃肠道不适)及相关并发症,包括过敏反应、艰难梭菌结肠炎和新型抗生素耐药病原体的出现。

研究设计与样本

  • 单中心回顾性队列研究,纳入2018年1月至2021年1月接受组织扩张器-假体置换二期乳房再造的359例患者。
  • 通过病历回顾收集患者及手术因素、抗生素预防信息和术后结局。
  • 采用多因素逻辑回归和似然比检验评估预防、协变量与并发症之间的关联。

主要发现

  • 患者按抗生素预防时长分组:0天组62例,1至6天组58例,7天及以上组239例。
  • 延长抗生素预防时长未改善3个月术后感染率的预测(p=0.581)。
  • 既往乳房感染史是感染的显著预测因素(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Implant-based breast reconstruction has a higher infection risk than cosmetic augmentation, leading to routine prophylactic antibiotic use. We previously found extended prophylaxis reduced infections during the first-stage reconstruction with tissue expander/acellular dermal matrix placement. However, the most appropriate antibiotic class and duration of prophylaxis in the second-stage reconstruction remains unclear. This retrospective study aims to address this gap, focusing on antibiotic selection and duration during second-stage implant-based breast reconstruction. METHODS: A single-center retrospective cohort study involved 359 patients undergoing second-stage breast reconstruction with tissue expander-implant exchange between January 2018 and January 2021. Chart reviews were performed to collect patient and surgical factors, antibiotic prophylaxis information, and postoperative outcomes. Multivariate logistic regression and likelihood ratio tests assessed associations between prophylaxis, covariates, and complications. RESULTS: Beyond a single perioperative dose of cefazolin, extended antibiotic prophylaxis did not significantly affect postoperative infection likelihood after second-stage breast reconstruction. Patients were grouped by antibiotic prophylaxis duration: 0 days (62 patients), 1 to 6 days (58 patients), and 7 or more days (239 patients). Extending antibiotic prophylaxis duration did not improve the prediction of 3-month postoperative infection rate (p = 0.581). A previous history of breast infection was a significant predictor for infection (p < 0.001). CONCLUSION: Extending antibiotics prophylaxis beyond a single preoperative dose of intravenous cefazolin does not reduce complication rates for patients undergoing second-stage breast reconstruction. Limiting prolonged prophylactic antibiotic use beyond the anesthetic period may reduce side effects (e.g., upset GI tract) and associated complications, including allergic reactions, Clostridium difficile colitis, and the emergence of new antibiotic-resistant pathogens.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Barrera J, Lakhlani D, Francis S, et al. The effect of prophylactic antibiotics on second-stage breast reconstruction: A retrospective analysis. J Plast Reconstr Aesthet Surg. 2025. PMID: 39933364. doi:10.1016/j.bjps.2025.01.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。